Joseph M. Mahady Joins Albemarle Board of Directors
Advertisement
lbemarle Corporation announced that its board of directors has elected Joseph M. Mahady to the company's board, effective February 1, 2012.
In 2009, Mahady retired from Wyeth Corporation, a global manufacturer of pharmaceutical products, following its acquisition by Pfizer and after 30 years with the company. At the time of his retirement, Mahady served as president – Wyeth Pharmaceuticals, responsible for directing worldwide operations for the company's $20 billion, 38,000 employee global pharmaceutical business. Prior to assuming these responsibilities, he served as president – global business from 2007 to 2008 and president – Americas & global business from 2005 to 2007.
From 1979 to 2005, Mr. Mahady held a number of strategic management positions at Wyeth Corporation including, president – Wyeth-Ayerst, vice president – healthcare systems and vice president – marketing and sales operations.
A native of New Jersey, Mahady earned a bachelor of science in pharmacy at St. John's University and a master's in business administration (MBA) at Fairleigh Dickinson University.
Other news from the department people
Most read news
More news from our other portals
Last viewed contents
Solvay to launch fluorochemicals production in China
Superior light-to-chemical energy conversion with Coulombic dyads - Scientists established a novel photocatalyst class that uses precious metals more efficiently
BASF: Strategy for profitable growth paying off
N-Realyzer | Elemental analyzers | C. Gerhardt
N-Realyzer | Elemental analyzers | C. Gerhardt - Elemental analysis of a new generation
Significant step forward in biofuels quest
Stokes'_law
Nobel Prize in Chemistry to Peter Agre and Roderick MacKinnon
New compound switches between liquid and solid states when exposed to light or heat
Marquard & Bahls' subsidiary Bomin and Linde to establish joint venture in liquefied natural gas for the marine market
